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Summary The tuberculin skin test (TST) and interferon-gamma release assays
(IGRA), namely, the QuantiFERON-TB Gold test (QFT), remain the standard immuno-
logical diagnostic tools for latent tuberculosis (TB) infection (LTBI). However, the
sub-optimal detection rates of both of these tests are major impediments in recog-QFT nizing the population at risk. This study was aimed at evaluating additional cytokines
besides interferon-gamma (IFN-) as biomarkers for improving LTBI diagnosis in the
tribal population of Melghat, India. Seventy-four close TB contacts were stratiﬁed
by QFT and TST results into: (i) QFT+/TST+ (n = 26), (ii) QFT+/TST− (n = 12), (iii)
QFT−/TST− (n = 35) and (iv) QFT−/TST+ (n = 1) groups. A panel of cytokines (IL-6, IL-
10, TNF- and IL-2R) was then evaluated in antigen-stimulated QFT cell-free culture
Abbreviations: BCG, Bacille Calmette Guerin; BMI, body mass index; CFP-10, 10 kDa culture ﬁltrate protein; CIIMS, Central India
nstitute of Medical Sciences; ELISA, enzyme-linked immunosorbent assay; ESAT-6, 6 kDa early secretory antigenic target; IFN-,
nterferon-gamma; IGRA, interferon-gamma release assay; IL-2, interleukin-2; IL-2R, interleukin-2 receptor; IL-4, interleukin-4; IL-5,
nterleukin-5; IL-6, interleukin-6; IL-10, interleukin-10; IL-12, interleukin-12; IL-18, interleukin-18; LTBI, latent TB infection; M.tb,
ycobacterium tuberculosis; MAHAN, Meditation Addiction Health AIDS Nutrition; NFHS, National Family Health Survey; PPD, puriﬁed
rotein derivative; PTB, pulmonary tuberculosis; QFT, QuantiFERON-TB Gold Test; TB, tuberculosis; TNF-, tumor necrosis factor-;
ST, tuberculin skin test; UNICEF, United Nations Children’s Fund.
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supernatants using IMMULITE-1000, an automated immunoassay analyzer. Cytokine
estimation showed signiﬁcantly higher levels of IL-6 in the QFT+/TST+ group, while
signiﬁcantly higher levels of IL-10 were found in the QFT−/TST− group. Correla-
tion analysis identiﬁed a positive correlation between IL-6 and the QFT response
(r = 0.6723, P < 0.0001), while a negative correlation was seen between QFT and IL-
10 expression (r =−0.3271, P = 0.0044). Similarly, IL-6 was positively correlated with
TST levels (r = 0.6631, P < 0.0001), and conversely, a negative correlation was found
between TST and IL-10 expression (r =−0.5698, P < 0.0001). The positive and negative
predictive values of IL-6 were found to be 92.59 and 93.33%, respectively, and the
positive and negative predictive values of IL-10 were 96.55 and 91.18%, respectively.
No signiﬁcant impact of the demographic characteristics on cytokine positivity was
observed. Our preliminary results suggest that the evaluation of additional cytokines
in QFT cell-free culture supernatants may be valuable for the identiﬁcation of LTBI.
with QFT and/or TST could markedly improve the detection
servations require investigation in larger well-characterized
-up studies to further conﬁrm the study outcome.
dulaziz University for Health Sciences. Published by Elsevier
ed.
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Melghat also has the highest number of malnutrition
cases in India [16]. The presence of malnutrition
has been widely recognized as a risk factor for theCombining IL-6 and IL-10
accuracy of LTBI. Our ob
cohorts along with follow
© 2015 King Saud Bin Ab
Limited. All rights reserv
Introduction
Despite worldwide efforts to minimize the burden
of tuberculosis (TB), developing countries, such
as India, continue to account for nearly 2.2 mil-
lion cases out of the global incidence rate of
8.7 million TB cases [1]. One of the major con-
tributing factors for the high incidence of TB in
India is the prevalence of latent TB infection
(LTBI) [2]. LTBI signiﬁcantly contributes to the pool
of active TB cases at a later stage, especially
in high risk TB environments [3]. The identiﬁca-
tion and prompt diagnosis of LTBI is therefore
required to substantially reduce the risk of devel-
oping active disease [4,5]. Commercially available
tools for screening populations at high risk for
TB include the tuberculin skin test (TST) and
more recently developed interferon-gamma release
assays (IGRAs), such as the QuantiFERON-TB Gold
test (QFT; Cellestis Limited, Victoria, Australia) [6].
These tests represent indirect markers of Mycobac-
terium tuberculosis (M.tb) exposure and measure
the cellular immune response against TB infection
[5]. However, the sub-optimal sensitivity of QFT and
the low speciﬁcity of TST remain critical issues in
the identiﬁcation of LTBI [7].
Although reports indicate interferon-gamma
(IFN-) to be a key cytokine that is involved
in the cell mediated immune response against
TB infection [8], its measurement alone is not
adequate for the accurate diagnosis of LTBI [9].
The protective and pathologic response of a host
to M.tb is complex and multifaceted, involv-
ing many components of the immune system
[10,11]. Numerous cytokines have pleiotropic and
d
a
iegulatory effects that participate in the host
efense and in inﬂammatory and tissue repair pro-
esses. These cytokines are classiﬁed into two
ypes: pro-inﬂammatory cytokines, which include
umor necrosis factor- (TNF-), interleukin-2
IL-2), interleukin-12 (IL-12), interleukin-18 (IL-
8), and anti-inﬂammatory cytokines, consisting
f interleukin-4 (IL-4), interleukin-5 (IL-5), and
nterleukin-10 (IL-10) [12,13]. Both types of
ecreted cytokines mutually regulate and inhibit
ach other’s functions and their balance and
ynamic changes control or predict the clinical
anifestations of active disease [14]. The identi-
cation of such cytokines in the whole blood of
xposed subjects previously stimulated with TB
ntigens may thus be useful for the accurate and
eliable diagnosis of LTBI.
Our study population included latently infected
ubjects from the malnourished tribal region of
elghat, Maharashtra, India. Melghat is a hilly
orested area located on the outskirts of the Amra-
ati District of Maharashtra with a population of
.3 million. The TB prevalence in the region is
stimated to be nearly 32% and is one of the lead-
ng causes of death in the economically productive
ge group of 16—40 years [15]. According to the
eports of United Nations Children’s Fund (UNICEF),
ational Family Health Survey (NFHS) and Medi-
ation Addiction Health AIDS Nutrition (MAHAN),evelopment of tuberculosis disease in those who
re infected. The reason for increased susceptibil-
ty to disease is attributed to malnutrition-induced
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mmunodeﬁciency, which affects the entire gamut
f immune responses [17]. The prevalence of TB
long with poor health status and limited resources
re the key risk factors making the population more
usceptible to latent infection. The early detection
f LTBI among the tribal population is there-
ore required for proper treatment to be initiated
nd to minimize the risk of progression to active
isease.
With the underlying aim of improving diagnoses
nd identifying novel biomarkers for LTBI, we car-
ied out multiple cytokine analyses in antigen
timulated QFT cell-free culture supernatants from
alnourished latent TB infected subjects of Mel-
hat. Our primary objective was to evaluate the
esponse of multiple cytokines in QFT cell-free cul-
ure supernatants for the effective screening and
mproved diagnosis of LTBI.
aterials and methods
thics statement
he study was approved by the Institutional Ethics
ommittee of the Central India Institute of Medical
ciences (CIIMS), Nagpur, and that of the Medita-
ion Addiction Health AIDS Nutrition (MAHAN) Trust,
mravati, Maharashtra, India, and is in accordance
ith The Code of Ethics of the World Medical Asso-
iation (Declaration of Helsinki). Written consent
orms were collected from each participant after a
etailed oral explanation about the study.
tudy design and participants
his was a prospective cohort study carried out over
period of 2 years in camps organized from ten
ifferent villages in the Melghat region of Maha-
ashtra, India, between May 2009 and June 2011.
total of 224 participants were enrolled based on
he information available from the Tribal Health
esearch Centre, Dharni run by the MAHAN Trust.
articipants were screened using requisite inclusion
nd exclusion criteria. Primarily, participants were
ecruited from families having at least one sputum-
ositive pulmonary tuberculosis patient (PTB) living
n the same household for at least 2 months prior
o the start of anti-TB medication, who had con-
inual exposure to TB and who were at high risk of
nfection.
Detailed information from all participants was
btained through a structured questionnaire con-
erning the risk factors for exposure to M.tb, the
uration of exposure and the type of contact with
he TB patient. Baseline characteristics, such as
t
w
T
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ge, gender, weight, height, occupation, education
nd behavioral factors, were also recorded. Other
nformation, such as any prior TST and the presence
f infections or illnesses experienced in the last 3
onths, was also documented. The BCG vaccina-
ion status was recorded based on the examination
f the BCG scar on the left forearm.
Malnourishment among the study participants
as determined by the information collected from
he questionnaires regarding dietary uptake, phys-
cal attributes and BMI values.
A total of 42 participants refused to give blood
nd were excluded from the study. The remaining
87 participants who matched the inclusion criteria
ere selected for the study. Amongst them, partic-
pants with an earlier history of TB or who had been
reviously treated with anti-TB medication (n = 57)
nd pregnant women (n = 10) were excluded from
he study. Children younger than 10 years (n = 13)
ere also excluded to avoid the impact of BCG
eactivity on the TST. The exposure period of the
articipants was characterized as moderate based
n living with active TB patients for 2—3 months
nd high for those living with active TB patients
or more than 3 months. Sixteen participants with
xposures of less than 1 month were not included in
he study, while 12 participants whose QFTs and/or
STs were not performed were also excluded from
he study. Thus, a total of 74 participants with
xposure periods varying from 3 months to 1 year
ere included in the present study as shown in
ig. 1. LTBI testing in all participants was performed
0—12 weeks after their last exposure to an active
ase.
All participants were negative for HIV infec-
ion and were not receiving any immunosuppressive
rugs. A control population was recruited from the
ame villages. All of the control cases selected for
he study were TST, sputum and culture negative;
ad no clinical or bacteriological features of TB;
ad normal chest radiographs with no history of
nti-TB medications; and had normal BMI values.
he tuberculin skin test (TST) and the
uantiFERON-TB Gold test (QFT-G)
he TST was performed by the Mantoux method
sing 10 tuberculin units (TU) of puriﬁed pro-
ein derivative (PPD) (Span Diagnostics, India).
he TST was administered intradermally by a
ertiﬁed technician and read after 48—72 h. In
ccordance with the National Tuberculosis Con-
rol Program, an induration of at least 10mm
as considered positive. Prior to performing the
ST, 10mL of venous blood were drawn into
wo heparin-containing tubes to perform the QFT
332 P.R. Bapat et al.
Figure 1 Study participation diagram. The ﬁgure presents the inclusion/exclusion criteria adopted for the recruitment
of the 74 participants. TST-tuberculin skin test with a cut-off point of at least 10mm; QFT− QuantiFERON-TB Gold
w
b
a
a
c
t
A
f
l
c
k
m
p
d
o
i
s
S
T
b
n
u
1with a cut-off point of at least 0.35 IU/ml.
assay. The QFT was performed according to the
manufacturer’s instructions. One tube contained
only heparin as a negative control (unstimulated
tube), and the other tube contained a peptide
cocktail simulating ESAT-6, CFP-10 and TB7.7 pro-
teins. The tubes were incubated for 20—24 h, after
which the plasma was harvested and the con-
centration of IFN- was measured by an ELISA
protocol. The IFN- values were calculated after
subtracting the unstimulated value, and a cut-off
value of 0.35 IU/mL was selected according to the
manufacturer’s instruction. The remaining plasma
samples were stored at −80 ◦C for later analyses of
cytokines.
Cytokine estimation in antigen-stimulated
QFT cell-free culture supernatants
The concentrations of additional cytokines (inter-
leukin-6, interleukin-10, interleukin-2 receptor
and tumor necrosis factor-) secreted in response
to antigen stimulation were determined in the QFT
cell-free culture supernatants from all 74 exposed
participants as well as healthy controls using the
IMMULITE-1000 Immunoassay System (Siemens
Healthcare Global), an automated microbead-
based analyzer that makes use of chemiluminescent
technology for analyte detection. In brief, plasma
samples from the study participants were incubated
c
t
w
with monoclonal antibodies coated on polystyrene
eads for 30min; thereafter, a polyclonal anti-
ntibody labeled with alkaline phosphatase was
dded before another 30-min incubation. Unbound
onjugate was washed away by axial centrifuga-
ion and the chemiluminescent substrate added.
fter 10min, light emission was measured and a
our-parameter logistic model was used to calcu-
ate the sample concentration from the standard
urves. All of the reagents were supplied in the
it, and the assays were performed using the
anufacturer’s instructions. The manufacturer’s
ackage insert states the upper and lower limits of
etection for cytokines in plasma, which are based
n the variability in the signal response observed
n a very large number of non-reactive patient
amples.
tatistical analysis
he frequencies (percentage) of the demographic,
ehavioral and clinical factors were measured on a
ominal scale. Statistical analysis was performed
sing the MedCalc statistical software (version
0.1.2.0). Individual cytokine concentrations were
ompared in the groups using Student’s T test with
wo-tailed probability, and a difference of P < 0.05
as considered to be signiﬁcant. Test concordance
as assessed using the kappa () statistic. The
Diagnosis of latent TB in a tribal population
correlation between cytokines and the QFTs/TSTs
was assessed using Pearson’s two-tailed correla-
tion test. PPV and NPV were calculated using a
diagnostic test evaluation (2× 2 table) (MedCalc
10.1.2.0) with healthy control subjects as the gold
standard. GraphPad Prism 5 (version 5.03) was used
to generate plots. Bivariate and multivariate logis-
tic regression analyses were performed with SPSS
software (version 22.0). A parsimonious regression
model was derived using Wald’s criterion for vari-
able selection. The resultingmodel ﬁtness was eval-
uated by referring to the Hosmer—Lemeshow test.
Odds ratios along with 95% conﬁdence intervals
were obtained for each factor, and themodel ﬁtness
was evaluated using a log-likelihood ratio test.
Results
Out of 224 exposed participants, 74 were included
in the ﬁnal analysis. The demographic and clin-
ical characteristics of the study participants are
shown in Table 1. Among the 74 participants, there
were 40 males and 34 females, with a mean age
of 34.43 years (range 12—65 years). Forty-four of
the study participants (59%) were in the 18—40
years age group. The BCG vaccination status was
conﬁrmed only in 22 (30%) participants. Sixty-one
percent of the participants were malnourished.
Thirty-eight (51%) of 74 participants had a posi-
tive QFT result, whereas 27 (36%) participants had
a TST greater than the positive threshold. There
was a good strength of agreement between the QFT
Table 1 Demographic and clinical characteristics of
population under study.
Characteristics Level No. (%)
Age (years) <18 10 (14)
18—40 44 (59)
>40 20 (27)
Gender Males 40 (54)
Females 34 (46)
Malnourished Yes 45 (61)
No 29 (39)
BCG Yes 22 (30)
No 52 (70)
Smoking Yes 11 (15)
Alcohol consumption Yes 7 (9)
Tobacco chewing Yes 16 (22)
QFT Results Positive (>0.35U/ml) 38 (51)
Negative (<0.35U/ml) 36 (49)
TST results Positive (>10mm) 27 (36)
Negative (<10mm) 47 (64)
Characteristics of 74 subjects exposed to M. tuberculosis and
at risk for LTBI are listed in the table. Percentages in different
categories are indicated in parentheses.
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nd TST assays (61/74, 82.43%,  = 0.651). Based on
he QFT and TST results, participants were catego-
ized into the following four groups, (i) QFT+/TST+
n = 26), (ii) QFT+/TST− (n = 12), (iii) QFT−/TST−
n = 35) and (iv) QFT−/TST+ (n = 1).
he comparison of the cytokine levels in
ifferent study groups
ytokine levels, in addition to IFN-, were esti-
ated in the whole blood of study participants after
timulation with TB-speciﬁc antigens. The concen-
ration of each cytokine was determined using the
MMULITE-1000 Immunoassay System. The levels of
ytokines in different groups stratiﬁed by the QFT
nd TST results are represented as box plots in
ig. 2. Among the pro-inﬂammatory cytokines, sig-
iﬁcantly higher levels of IL-6 were observed in the
FT+/TST+ group (median: 507.6 pg/ml) compared
o the QFT−/TST− group (median: 230.9 pg/ml)
P = 0.0015). However, no signiﬁcant difference
as observed in the levels of TNF- and IL-2R
etween different groups. In contrast, signiﬁcantly
igher levels of anti-inﬂammatory cytokine IL-10
ere found in the QFT−/TST− group (median:
8.1 pg/ml) compared to the QFT+/TST+ group
median: 10.1 pg/ml) (P = 0.0013). Cytokine estima-
ion was also performed in the antigen-stimulated
FT cell-free culture supernatants of healthy
ontrol subjects from the same population. In
omparison with exposed individuals, the control
opulation had considerably lower cytokine lev-
ls. IL-6 levels were signiﬁcantly higher in the
FT+/TST+ (P < 0.0001) group and in QFT−/TST−
roup (P = 0.001) compared to the control group.
imilarly, IL-10 was signiﬁcantly higher in the
FT+/TST+ group (P = 0.007) and in the QFT−/TST−
roup (P < 0.0001) compared to the control group.
able 2 presents the mean concentrations of the
our cytokines in the antigen-stimulated QFT cell-
ree culture supernatants of exposed and healthy
ontrol subjects.
he correlation between cytokine
xpression and the magnitude of the
FT/TST responses
o determine the diagnostic speciﬁcity of
ytokines, we further analyzed the correla-
ion between the magnitude of the QFT and TST
esponses with the cytokine levels for individual
atients. Fig. 3 shows the correlation between
he concentrations of cytokines in plasma from
atent TB infected individuals and their QFT and
ST responses. We observed a positive correlation
334 P.R. Bapat et al.
Figure 2 Responses of four cytokines to speciﬁc M.tb antigens. The box plots represent the cytokine levels of IL-6, IL-
10, IL-2R and TNF- in the antigen-stimulated QFT cell-free culture supernatants of the different study groups stratiﬁed
by the QFT and TST results as well as in healthy control subjects. The median concentration of each biomarker is shown
in each panel. Horizontal lines indicate a statistically signiﬁcant difference between groups. *P < 0.05, **P < 0.005,
***P < 0.0005.
Table 2 Median concentrations of cytokine production in different study groups.
Cytokine QFT+/TST+
(n = 26)
QFT+/TST−
(n = 12)
QFT−/TST−
(n = 35)
QFT−/TST+
(n = 1)
Healthy controls
(n = 16)
IL-6 (pg/ml) 507.6***,# 426* 230.9**,# 939 3.8
IL-10 (pg/ml) 10.9*,† 14* 28.1***,† 19.3 5.8
IL-2R (U/ml) 463.4 413.8 593.1** 788 424.5
TNF- (pg/ml) 31.2*** 27.6 12.5 131 5.74
Cytokine responses to combination of M.tb antigens (ESAT-6, CFP-10 and TB7.7) are listed in the table. Cytokine concentrations
were estimated in antigen stimulated QFT cell-free culture supernatants by IMMULITE-1000 Immunoassay system. Statistical
signiﬁcance was determined by Student’s T-test. All experimental groups were compared against healthy control group. P values
indicated as *P < 0.05, **P < 0.005, ***P < 0.0005 were considered statistically signiﬁcant.
o# P = 0.0015 for QFT+/TST+ vs QFT−/TST− group.
† P = 0.0013 for QFT+/TST+ vs QFT−/TST− group.
between the expression levels of IL-6 (r = 0.6723,
P < 0.0001) and the QFT response, while we
observed a negative correlation between QFT
and IL-10 expression (r =−0.3271, P = 0.0044)
(Fig. 3a and b). Regarding the TST response, we
o
l
a
Tbserved similar results wherein the expression
f IL-6 was positively correlated with the TST
evels (r = 0.6631, P < 0.0001). On the other hand,
negative correlation was observed between the
ST and IL-10 expression (r =−0.5698, P < 0.0001)
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Figure 3 The correlation analysis between the QFT/TST results and cytokine expression: regression graphs show the
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Torrelation of the magnitude of the QFT/TST levels and t
f 74 exposed individuals from Melghat.
Fig. 3c and d) Regression analysis between TNF-,
L-2R expression and the QFT/TST responses did
ot identify a statistically signiﬁcant correlation
Fig. S2).
mproved diagnostic performance by a
ombination of biomarkers
he participants with cytokine levels greater than
he normal detection limit (5.9 pg/ml for IL-
, 9.1 pg/ml for IL-10, 710 U/ml for IL-2R and
.1 pg/ml for TNF-) were regarded as positive,
nd those below the detection limit were other-
ise regarded as negative (Table 3). Of the panel
f cytokines, IL-6 and IL-10 had the highest posi-
ivity rate. Fifty-two out of 74 (70%) participants
ere positive for IL-6, and 45 out of 74 (61%) were
ositive for IL-10. IL-2R and TNF- had positivity
ates of 23 and 43%, respectively; however, they
ere less signiﬁcant than the QFT positivity rate
f 51% and the TST positivity rate of 36%. We fur-
her assessed the diagnostic performance of all of
he cytokines when combined with the QFT and the
ST. In the QFT+/TST+ group, IL-6 had a 96% posi-
ivity rate. IL-6 had the highest positivity rate (91%)
n the QFT+/TST− group as well. In the QFT−/TST−
roup, we observed a maximum positivity rate for
Q
y
c
txpression of different cytokines in the QFT supernatants
L-10 (80%), followed by a 43% positivity rate for
L-6.
redictive values of cytokines in the
etection of LTBI
o further evaluate the diagnostic utility of
ytokines for LTBI, the positive and negative pre-
ictive values (PPV and NPV) were calculated for
he individual cytokines in each group (Table 4). IL-
had the highest positive and negative predictive
alues in the QFT+/TST+ group (92.59 and 93.33%,
espectively). IL-10, on the other hand, had the
ighest positive and negative predictive values in
he QFT−/TST− group (96.55 and 91.18%, respec-
ively). TNF- also had a signiﬁcant PPV in the
FT+/TST+ group (88.89%). However, its negative
redictive value was found to be considerably low
ompared to that of IL-6 and IL-10.
he association between demographic
haracteristics and cytokine responses
he association between cytokine positivity and the
FT/TST results was studied through bivariate anal-
sis. Cytokine positivity was the outcome, and the
oncordant/discordant sets were treated as predic-
ors (the QFT−/TST+ group was excluded from the
336 P.R. Bapat et al.
Table 3 Detection rates of individual cytokines and cytokines in combination with QFT and TST.
Cytokines Normal
Detection Limit
Total (%)
(n = 74)
QFT+/TST+
(n = 26)
QFT+/TST−
(n = 12)
QFT−/TST−
(n = 35)
QFT−/TST+
(n = 1)
IL-6 +ve >5.9 pg/ml 52 (70) 25 11 15 1
IL-6 −ve <5.9 pg/ml 22 (30) 1 1 20 0
IL-10 +ve >9.1 pg/ml 45 (61) 9 7 28 1
IL-10 −ve <9.1 pg/ml 29 (39) 17 5 7 0
IL-2R +ve >710 U/ml 17 (23) 4 2 10 1
IL-2R −ve <710U/ml 57 (77) 22 10 25 0
TNF- +ve >8.1 pg/ml 32 (43) 16 6 9 1
TNF- −ve <8.1 pg/ml 42 (57) 10 6 26 0
Responders with cytokine level greater than the normal detection limit were regarded as positives and those below detection
limit were regarded as negatives. Table shows the number of positive responders in each study group.
Table 4 Positive and negative predictive values of cytokines for LTBI in different groups.
Cytokines Positive predictive value Negative predictive value
QFT+/
TST+
QFT+/
TST−
QFT−/
TST−
QFT−/
TST+
QFT+/
TST+
QFT+/
TST−
QFT−/
TST−
QFT−/
TST+
IL-6 92.59% 84.62% 88.24% 33.33% 93.33% 93.33% 41.18% 100.00%
IL-10 85.00% 87.50% 96.55% 50.00% 46.88% 75.00% 91.18% 100.00%
IL-2R 57.14% 40.00% 76.92% 25.00% 37.14% 56.52% 34.21% 100.00%
TNF- 88.89% 75.00% 81.25% 33.33% 58.33% 70.00% 35.00% 100.00%
Table shows the PPV and NPV of cytokines in those with LTBI categorized into different concordant/discordant sets. The predictive
tab
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tvalues were calculated using Diagnostic test evaluation (2× 2
standard.
model because of the lack of a substantial number
of individuals in the group). Negative concordance
(QFT−/TST−) was considered to be the reference
level. The association of risk factors (baseline char-
acteristics) and the QFT/TST results with cytokine
positivity was studied through multinomial multi-
variable logistic regression obtained in terms of the
adjusted odds ratio, as shown in Table 5. The results
indicate that the QFT/TST groups were signiﬁ-
cantly associated with cytokine positivity. For IL-6,
the concordant and discordant groups (QFT+/TST+,
and QFT+/TST−) had a signiﬁcantly higher odds
ratio of 33.33 (95% CI: 4.05—274.36) and 14.67
(95% CI: 1.7—126.39), respectively, compared to
the QFT−/TST− group. Similar results were seen
for TNF-wherein the odds ratio was highest for the
QFT+/TST+ group (4.62, 95% CI: 1.54—13.81). How-
ever, for IL-10 and IL-2R, there was a decrease in the
odds ratio in the discordant and concordant groups
compared to the reference group. The inclusion
of demographic characteristics (gender, malnutri-
tion, BCG status, smoking, alcohol consumption and
tobacco chewing) in the multinomial multivariate
regression model did not demonstrate a signiﬁcant
deviation in the odds ratios, with the exception
of TNF-, in which the adjusted odds ratio had a
four-fold increase.
i
n
dle) (MedCalc 10.1.2.0) with healthy control subjects as gold
iscussion
urrently, IFN- is the only soluble immunological
arker dedicated to LTBI screening. Because of the
imitations associated with TST, several reports sug-
est the superior utility of the QFT over the TST for
he diagnosis of LTBI [18]. However, the QFT results
lso exhibit dynamic variability. A single IGRA test
ay therefore fail to predict infection progres-
ion; however, a combination of IGRA tests with
ther complementary markers may provide a more
ccurate diagnosis or prediction of disease [19].
oreover, in settings where TB infection is associ-
ted with other risk factors, such as malnutrition,
dditional biomarkers along with the existing tests
or LTBI need to be evaluated for accurate diag-
osis and treatment to be initiated. The tribes of
elghat are among one such population with a high
revalence of both LTBI and malnutrition. Due to
he limitations associated with both of the existing
iagnostic tests for LTBI, we evaluated a panel of
ytokines in antigen-stimulated QFT cell-free cul-
ure supernatants for the LTBI diagnostic accuracy
n a tribal population.
Several reports have established that mal-
utrition is a complex syndrome involving the
ysfunction of the whole spectrum of immune
Diagnosis of latent TB in a tribal population
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esponses, thus increasing susceptibility to infec-
ion and disease. Apart from malnutrition, the type
f exposure to an active TB case also inﬂuences the
isk of latent infection. Household exposure due
o prolonged physical contact or exposure within
he community due to religious gatherings, cultural
ractices and recreational activities signiﬁcantly
ffects the risk of TB exposure and the subsequent
mmune response against it [20].
To evaluate the diagnostic utility of cytokines,
FT and TST analyses were carried out, followed by
ytokine evaluations of the antigen-stimulated QFT
ell-free culture supernatants of all of the partici-
ants. The study population was then stratiﬁed on
he basis of the QFT and TST results into concord-
nt and discordant sets, and the results were then
orrelated with the selected panel of cytokines
TNF-, IL-6, IL-10 and IL-2R). It was observed that
n the QFT+/TST+ group, 25 of 26 (96%) subjects
ad a positive IL-6 response, suggesting a good
orrelation between the QFT/TST results and IL-6.
he patterns of cytokine responses in the different
roups also indicate that IL-6 is secreted in sig-
iﬁcantly higher concentrations in the QFT+/TST+
roup compared to the QFT−/TST− group. Like IFN-
, IL-6 is involved in the T helper type 1 (Th1)
ellular immune response, which is involved in the
learance of M.tb [21]. IL-6 has multiple roles,
ncluding inﬂammation, hematopoiesis and the dif-
erentiation of T cells [22]. The anti-inﬂammatory
ytokine IL-10, in contrast, had suppressed levels
n 17 of the 26 (65%) subjects in the QFT+/TST+
roup. On the other hand, the highest levels of this
ytokine were observed in the QFT−/TST− group.
L-10 is involved in the Th2 response and exerts
negative inﬂuence on the immune response. IL-
0 secreted by macrophages and T cells during
nfection and possesses macrophage deactivating
roperties including the down regulation of IFN-
production [11,23]. Our results are consistent
ith recent ﬁndings suggesting that control of
B in the latent stage is not only associated
ith an increased expression of Th1 cytokines
ut also with the suppression of Th2 cytokines
10,24]. The balance between the two types of
ytokines (pro- and anti-inﬂammatory) is reﬂected
n the resultant host resistance against infection
25].
TNF-mediates the early inﬂammatory response
gainst pathogens and is produced by a variety of
ells, including macrophages, lymphocytes, neu-
rophils, mast cells, and endothelial cells. It is
onsidered to be necessary for the removal of
acteria from inﬂammatory lesions [26,27]. Consis-
ent with earlier reports, we did ﬁnd higher levels
f TNF- in the QFT+/TST+ group compared to the
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other study groups, but the observed values were
not signiﬁcant [24].
The QFT−/TST− group with TST indurations
of <10mm and QFT values <0.35U/ml (generally
observed in healthy controls) had a 43% positivity
rate for IL-6 and an 80% positivity rate for IL-10, sug-
gesting that in such cases, QFT is unable to detect
infection, although effector T cells directed against
TB antigens are present in these exposed subjects.
This group is of interest because in the absence
of any evidence of LTBI, we observed a positive
cytokine response.
Although the QFT−/TST+ group was not included
in the analysis due to the lack of sufﬁcient data,
the reason for the high TST and cytokine responses
in this individual requires further consideration.
One of the reasons for the observed discordance
could be due to a false negative result caused by
malnutrition-induced antigen-speciﬁc immunosup-
pression. An alternative explanation may be a false
positive result due to nontuberculous mycobacteria
or BCG vaccination. However, the fact that the indi-
vidual from this category had up-regulated cytokine
expression in response to antigen stimulation sug-
gests that the individual was indeed infected with
TB at some point in the past. Such discordance
in the QFT and TST results has been previously
reported [28].
Because the TST and IGRAs are the only diag-
nostics tools for LTBI, other cytokines that have
expressions that are correlated with these test out-
comes may be useful in the characterization of
M.tb infection. We therefore evaluated the corre-
lation between the magnitude of the QFT and TST
response and the magnitude of the responses of our
panel of cytokines. Correlation analysis suggested
that the individuals with the largest TST results and
the highest QFT values were the ones with the high-
est IL-6 and lowest IL-10 concentrations, indicating
that these cytokines are important predictive mark-
ers of LTBI.
Furthermore, an optimal diagnostic tool should
have the ability to discriminate between the target
condition and health. This discriminative potential
was quantiﬁed by evaluating the predictive val-
ues of each cytokine. Based on the results, IL-6
and IL-10 had the highest positive predictive values
(PPV) (92.59 and 96.55%, respectively), indicating
the high probability of having an infection in the
subjects with positive results. Similarly, the high
negative predictive values (NPV) of IL-6 and IL-
10 (93.33 and 91.18%, respectively) signiﬁed the
probability of not having an infection in the indi-
viduals with negative test results. These values thus
demonstrated the high accuracy and speciﬁcity of
I
d
tP.R. Bapat et al.
he two cytokines in detecting the presence of
nfection in the exposed population.
The impact of demographic characteristics (age,
ender, malnutrition, BCG vaccination status,
moking, alcohol consumption and tobacco chew-
ng) on cytokine positivity was studied through
ultivariate regression analysis to determine if
hese factors inﬂuence the test outcomes. In our
revious study, age was regarded as a strong pre-
ictor for QFT positivity [29] (QFT positivity was
ighest in >40 age group). Similarly, there are
eports on the association between smoking and
TBI [30]. Such potential confounders or risk factors
ight therefore weigh upon the speciﬁcity of the
est and inﬂuence the result. In the present study,
owever, we found no such impact of demographic
haracteristics on the test outcomes, indicating
hat these factors were not signiﬁcant predictors of
ytokine positivity and thereby validated the diag-
ostic speciﬁcity of the cytokines.
The panel of cytokines was also evaluated in
ealthy control individuals from the same popula-
ion; however, in contrast, all cytokines were found
o be within the normal detection limits when com-
ared with the TB-exposed individuals.
The results of the present study have demon-
trated that individuals without a history of
uberculosis and exposure to M.tb had a Th1 (IFN-
, TNF- and IL-6) and Th2 response similar to that
ound by Demissie, with relatively low IFN- pro-
uction when compared to IL-10 [31,32]. There are
ew published reports in the literature on the pro-
uction of IL-10 by household contacts of patients
f tuberculosis. According to Olobo et al., these
evels are due to the stimulation of mycobacterial
ntigens that induce IL-10 production by mono-
uclear cells [33]. IL-10 is probably involved in the
atural defense against excessive pro-inﬂammatory
esponses generated by IL-6 and TNF- [34]. There-
ore, the simultaneous presence of IL-10 and IL-6
ay provide protection to the household contacts
f TB patients. Recently, John et al. also identiﬁed
L-6 and IL-10 as clinically relevant biomarkers that
re required for the improved diagnosis, prevention
nd treatment of tuberculosis [35].
There are few reports on the evaluation of
ytokines as biomarkers for M.tb infection in the
ndian population. Dhanasekaran et al. evaluated
he response of multiple cytokines for the diagno-
is of LTBI in an exposed South Indian population
36]. Anbarasu et al. reported IL-6 to be a promis-
ng diagnostic marker in the Indian population [37].
n the present study, we report IL-10 to be a useful
iagnostic biomarker of LTBI in the Indian popula-
ion.
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[iagnosis of latent TB in a tribal population
Although our results suggest important roles of
L-6 and IL-10 in LTBI diagnosis, further evaluation
f these ﬁndings in a larger number of exposed
ndividuals along with proper follow-up studies
re needed. Such studies may further help us to
stablish the roles of both IL-6 and IL-10 in the
rognosis of TB disease following therapeutic meas-
res. Furthermore, an evaluation of additional T
ell-speciﬁc cytokines in QFT supernatants may be
elpful for improving and validating the existing
iagnostic tests.
onclusions
n conclusion, the measurement of multiple
ytokines in response to TB infection can be use-
ul for LTBI diagnosis in the tribal population of
elghat. Among the panel of cytokines, IL-6 and
L-10 appear to be the most important diagnos-
ic markers of M.tb infection. An evaluation of
uch cytokines, in addition to IFN-, could markedly
mprove the performance of IGRAs in the effective
creening of individuals with LTBI in the TB-exposed
ribal population. Our observations require further
nvestigation in larger well-characterized cohorts,
n addition to follow-up, to further conﬁrm the
tudy outcome.
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